China Cancer Test Market will be US$ 24 Billion by 2022 due to Rising Cancer cases & Innovation in Technology
For More Information: http://www.renub.com/china-cancer-test-market-will-be-us-24-billion-by-2022-due-to-rising-cancer-cases-and-innovation-in-technology-62-nd.php By the end of the year 2022, China Cancer Test Market is expected to cross US$ 24 Billion. With the speedy economic development of China, incredible changes have been seen in the Chinese population because of environmental conditions, dietary intake, chronic infection, lifestyle factors and nutritional status. As a result, the cancer upshot in China has increased over the past three decades. According to National Cancer Registry Centre, the total national cancer cases and cancer deaths in China were approximately 3.5 million and 2.5 million per year respectively in the year 2009. With the cases like age standardized rate with the world standard population [WASR]) of 191.72 per 100,000 and mortality (WASR) of 115.65 per 100,000, respectively. Moreover, the total cancer rate was top in urban areas than in rural areas. 26 types of cancers were as follows: Lip, oral cavity, & pharynx (except nasopharynx), Nasopharynx, Esophagus, Stomach, Colorectum, Liver, Gallbladder, Pancreas, Larynx, Lung, Other thoracic organs, Bone, Melanoma, of the skin, Breast, Cervix, Uterus, Ovary, Prostate, Testis, Kidney, Bladder, Brain, CNS, Thyroid, Lymphoma, Leukemia and All other sites and unspecified. In Male: Lung Cancer is the most predominant cancer and is mainly driven by adult males, half of Chinese men are expected to be current smokers compared to women, followed by Colorectal Cancer, Liver Cancer, Brain, CNS, Esophageal Cancer and Breast Cancer (not in same chorological order). In Female: Lung cancer cases are less in women as compared to men but other cancers were Liver and Breast Cancer, Uterus and Ovarian Cancer are other most common cancers. Some other Cancers studied in this report are Lip, Oral Cavity, & Pharynx, Nasopharynx, Pancreas, Bone, Prostate, Luekemia, Bladder, Kidney and Lymphoma. Get Free 10% Customization in This Report Access full Research: http://www.renub.com/china-cancer-test-market-volume-forecast-male-female-p.php
119 views • 10 slides
